DNMT3A and breast cancer: When it comes to DNMT1 and DNMT3A, studies have demonstrated elevated expression levels within BC cells [9,10,11,12,13]; therefore, studying them is essential for a better understanding of the disease’s progression and potential therapeutic targets.